Leukoencephalopathies: Clinical Trials

416 trials for Leukoencephalopathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

183 completed, 75 recruiting, 71 unknown, 26 terminated. 109 Not applicable, 74 Phase 2, 41 Phase 3, 36 Phase 1, 10 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable109Completed 59, Unknown 21, Recruiting 17, Active not recruiting 4, Not yet recruiting 4, Terminated 4
Phase 274Completed 32, Unknown 14, Terminated 9, Recruiting 6, Withdrawn 6, Active not recruiting 3, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Phase 341Completed 26, Terminated 5, Unknown 5, Active not recruiting 3, Not yet recruiting 1, Recruiting 1
Phase 136Completed 14, Recruiting 6, Unknown 5, Withdrawn 4, Terminated 3, Suspended 2, Active not recruiting 1, Enrolling by invitation 1
Phase 410Completed 6, Active not recruiting 2, Enrolling by invitation 1, Terminated 1
Early Phase 14Completed 2, Active not recruiting 1, Withdrawn 1

Follow Leukoencephalopathies: new trials by email Literature Review of Leukoencephalopathies trials Research Report on Leukoencephalopathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD
Lentiviral TYF-ARSA correction of patient's autologous HSCs - Metachromatic Leukodystrophy (MLD)
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-06-012026-09-01
IT and IV Lentiviral Gene Therapy for X-ALD
Intrathecal and intravenous LV gene therapy - X-linked Adrenoleukodystrophy
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute302027-06-012026-09-01
Direct Lentiviral Injection Gene Therapy for MLD
Intrathecal and intravenous LV gene therapy - Metachromatic Leukodystrophy (MLD)
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-05-312026-09-01
Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia
Investigational Combination Product - Periventricular Leukomalacia, White Matter Disease
Early Phase 1WithdrawnMGAM LLC2027-01-012025-07-22
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)
PLX-200 - Lysosomal Storage Disorders, Sandhoff Disease
Phase 2Not yet recruitingPolaryx Therapeutics, Inc.242026-12-012026-07-31
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
Mini-mental State Examination, Addenbrooke's Cognitive Examination, Speech Task - Picture Description - Dementia (Diagnosis), Alzheimer Dementia (AD)
Not yet recruitingZealand University Hospital4402026-11-012026-09-02
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study
Music Training Intervention, Music Listening - Multiple Sclerosis, Pathologic Processes
Not applicableRecruitingUniversity of Texas at Austin642026-08-102026-08-17
IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis
IDP-023, Ocrelizumab, Interleukin-2 - Multiple Sclerosis, Primary Progressive Multiple Sclerosis (PPMS)
Phase 1SuspendedIndapta Therapeutics, INC.342026-06-302025-04-30
Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study
Brincidofovir - Progressive Multifocal Leukoencephalopathy
Phase 2RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)242026-06-052026-07-22
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
Ozanimod - Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy
RecruitingBristol-Myers Squibb152026-06-042026-07-29
OPM- MEG in Non-immune And iMmune-medIated Neurological Disease
OPM- Magnetoencephalography - Autoimmune Encephalitis (AE), Acute Disseminated Encephalomyelitis
Not applicableRecruitingAston University902026-05-152026-10-22
The Aim of the Present Study is to Determine Outcome Predictors in Children Who Were Diagnosed as Acute Disseminated Encephalomyelitis (ADEM).
Acute Disseminated Encephalomyelitis, Encephalomyelitis
Not yet recruitingAssiut University252026-03-292026-04-20
T-cell Therapy in Patients With PML
Application of T-lymphocytes - Progressive Multifocal Leucoencephalopathy (PML)
Phase 2RecruitingHannover Medical School232026-02-062026-10-15
Single Patient Investigational Treatment for Cree Leukoencephalopathy
Fosigotifator - Cree Leukoencephalopathy
Not applicableActive not recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre12025-12-032026-01-16
Making Connections Thru Music
Volunteer Led Making Connections Thru Music, Staff Led Making Connections Thru Music - Dementia, Alzheimer Disease
Not applicableRecruitingHopeful Aging1962025-12-012026-09-15
High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in Immune Cell Network
Blood test - Acute Disseminated Encephalomyelitis, Encephalitis Autoimmune
Not applicableRecruitingUniversity Hospital, Angers202025-11-162026-04-27
Music Effects on Dementia
Music Therapy - Dementia, Music Therapy
Not applicableCompletedInstituto Nacional de Geriatria, Mexico72025-11-102026-04-21
Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment
Cerogrin, Sham Device - Vascular Dementia, Mild Cognitive Impairment
Not applicableActive not recruitingNeurogrin Inc.242025-10-152026-09-18
Natural History and Genotype-Phenotype Correlations in Mitochondrial Leukoencephalopathies
Mitochondrial, Leukoencephalopathies
RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1002025-09-152026-10-09
Inectolizumab With Steroid Optimization in Newly Treated NMOSD
Inebilizumab + Rapid Steroid Tapering group, Inebilizumab + Standard Steroid Tapering group - Neuromyelitis Optica, Autoimmune Diseases
Not applicableNot yet recruitingFirst Affiliated Hospital of Wenzhou Medical University252025-09-012025-09-08

Showing 20 of 416. Sign in to see all of them.

Narrower conditions

Dementia, Vascular (181)  ·  Alzheimer Disease (116)  ·  Dementia (100)  ·  Cognitive Dysfunction (66)  ·  Adrenoleukodystrophy (62)  ·  Lewy Body Disease (54)  ·  Leukodystrophy, Metachromatic (49)  ·  Mixed Dementias (41)  ·  Multiple Sclerosis (36)  ·  Leukodystrophy, Globoid Cell (31)  ·  Leukoencephalopathy, Progressive Multifocal (29)  ·  Demyelinating Diseases (26)  ·  Frontotemporal Dementia (26)  ·  Demyelinating Autoimmune Diseases, CNS (24)

Broader conditions

Brain Diseases (410)  ·  Central Nervous System Diseases (407)  ·  Nervous System Diseases (397)  ·  Cardiovascular Diseases (198)  ·  Vascular Diseases (196)  ·  Cerebrovascular Disorders (192)  ·  Mental Disorders (191)  ·  Intracranial Arterial Diseases (186)  ·  Arterial Occlusive Diseases (182)  ·  Arteriosclerosis (181)  ·  Intracranial Arteriosclerosis (181)  ·  Neurocognitive Disorders (178)  ·  Demyelinating Diseases (175)  ·  Nutritional and Metabolic Diseases (166)

Interventions

Alemtuzumab (6)  ·  Stem Cell Transplantation (6)  ·  Blood Specimen Collection (5)  ·  Donepezil (5)  ·  Cyclophosphamide (4)  ·  Exercise (4)  ·  Galantamine (4)  ·  Busulfan (3)  ·  Hematologic Tests (3)  ·  Lorenzo's oil (3)  ·  Magnetic Resonance Imaging (3)  ·  Melphalan (3)  ·  Music Therapy (3)  ·  Risperidone (3)  ·  trierucate (3)

Sponsors

Masonic Cancer Center, University of Minnesota (8)  ·  Shire (8)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  Hopeful Aging (6)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (6)  ·  Biogen (5)  ·  Dongzhimen Hospital, Beijing (5)  ·  Genetix Biotherapeutics Inc. (5)  ·  University of Pennsylvania (5)  ·  Dunjin Chen (4)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (4)  ·  Ionis Pharmaceuticals, Inc. (4)  ·  Mayo Clinic (4)  ·  National Taiwan University Hospital (4)  ·  University Health Network, Toronto (4)

Countries

United States (183)  ·  China (41)  ·  France (40)  ·  Germany (36)  ·  United Kingdom (30)  ·  Italy (28)  ·  Netherlands (25)  ·  Canada (23)  ·  Spain (18)  ·  Australia (14)  ·  Denmark (10)  ·  Brazil (9)  ·  Japan (8)  ·  Argentina (7)  ·  Russia (7)

Top investigators

Paul Orchard, MD (6)  ·  Joanne Kurtzberg, MD (5)  ·  Irene CM Cortese, M.D. (4)  ·  Michael Skrajner, MA (4)  ·  Stephen Huhn, MD (4)  ·  Patrick Aubourg, MD, PhD (3)  ·  Adeline Vanderver, MD (2)  ·  Aimee Spector, PhD, DClinPsych (2)  ·  Caroline Sevin, MD, PhD (2)  ·  Carolyn Phillips, PhD (2)  ·  Dunjin Chen (2)

Results publications

PMID 21586746, PMID 33332761, PMID 39383458, PMID 23867200, PMID 31566651, PMID 33189083, PMID 36196048, PMID 39383459, PMID 40049590, PMID 40267426, PMID 10084637, PMID 10356105, PMID 10496251, PMID 11001602, PMID 11231629, PMID 11399225, PMID 11965273, PMID 12040306, PMID 12064356, PMID 12633121, PMID 12973660, PMID 14505162, PMID 15364702, PMID 15784740, PMID 16002461, PMID 16194720, PMID 16831964, PMID 17186320, PMID 18294247, PMID 18674411, PMID 19347838, PMID 19500421, PMID 19833552, PMID 19891819, PMID 19892975, PMID 19933977, PMID 20204386, PMID 20386637, PMID 20656516, PMID 20880607, PMID 20930266, PMID 21118724, PMID 21259015, PMID 21474353, PMID 21717193, PMID 21738597, PMID 21908805, PMID 22067635, PMID 22123780, PMID 22133740

NIH funding

2023 (3), 2008 (2), 2015 (2), 2017 (2), 2018 (2), 2019 (2), 2025 (2), R01AG056715 (2), U54NS078059 (2), 1RF1AG074608-01 (1), 2005 (1), K23HD101667 (1), K23NS087151 (1), R01AG011378 (1), R01AG023116 (1)